ANNX
Price
$2.49
Change
-$0.22 (-8.12%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
273.19M
65 days until earnings call
SLN
Price
$5.33
Change
-$0.26 (-4.65%)
Updated
Jun 13 closing price
Capitalization
212.54M
Interact to see
Advertisement

ANNX vs SLN

Header iconANNX vs SLN Comparison
Open Charts ANNX vs SLNBanner chart's image
Annexon
Price$2.49
Change-$0.22 (-8.12%)
Volume$17.38K
Capitalization273.19M
Silence Therapeutics
Price$5.33
Change-$0.26 (-4.65%)
Volume$77.79K
Capitalization212.54M
ANNX vs SLN Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. SLN commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (ANNX: $2.49 vs. SLN: $5.33)
Brand notoriety: ANNX and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 66% vs. SLN: 37%
Market capitalization -- ANNX: $273.19M vs. SLN: $212.54M
ANNX [@Biotechnology] is valued at $273.19M. SLN’s [@Biotechnology] market capitalization is $212.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANNX and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 3 bearish.
  • SLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than SLN.

Price Growth

ANNX (@Biotechnology) experienced а -4.23% price change this week, while SLN (@Biotechnology) price change was -2.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 18, 2025.

SLN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANNX($273M) has a higher market cap than SLN($213M). SLN YTD gains are higher at: -22.529 vs. ANNX (-51.462). SLN has higher annual earnings (EBITDA): -71.65M vs. ANNX (-151.48M). ANNX has more cash in the bank: 312M vs. SLN (137M). SLN has less debt than ANNX: SLN (60K) vs ANNX (29M). SLN has higher revenues than ANNX: SLN (27.7M) vs ANNX (0).
ANNXSLNANNX / SLN
Capitalization273M213M128%
EBITDA-151.48M-71.65M211%
Gain YTD-51.462-22.529228%
P/E RatioN/AN/A-
Revenue027.7M-
Total Cash312M137M228%
Total Debt29M60K48,333%
TECHNICAL ANALYSIS
Technical Analysis
ANNXSLN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 2 days ago
89%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIEMX8.21N/A
N/A
Virtus SGA Emerging Markets Equity I
PNOPX120.61N/A
N/A
Putnam Sustainable Leaders A
BIOPX49.23N/A
N/A
Baron Opportunity Retail
FKICX6.29N/A
N/A
Fidelity Small Cap Stock K6
ARTHX24.04-0.03
-0.12%
Artisan Global Equity Investor

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-8.12%
IDYA - ANNX
47%
Loosely correlated
-0.45%
CCCC - ANNX
46%
Loosely correlated
+3.70%
CRNX - ANNX
44%
Loosely correlated
-1.24%
ERAS - ANNX
44%
Loosely correlated
-3.27%
ZYME - ANNX
44%
Loosely correlated
-3.28%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-4.57%
CLLS - SLN
43%
Loosely correlated
-2.69%
CMVLF - SLN
38%
Loosely correlated
N/A
ANNX - SLN
37%
Loosely correlated
-8.12%
IDYA - SLN
37%
Loosely correlated
-0.45%
ABCZF - SLN
36%
Loosely correlated
N/A
More